Anoro Ellipta (umeclidinium and vilanterol inhalation powder) is now available by prescription in US retail pharmacies, according to a news announcement by manufacturers GlaxoSmithKline and Theravance Inc. Anoro Ellipta is the first once-daily product approved in the US that combines two long-acting bronchodilators in a single inhaler for the maintenance treatment of COPD, the companies said.
- See more at: http://www.rtmagazine.com/2014/04/anoro-ellipta-available-in-us-treatment-copd/#sthash.ZrizZvh7.dpuf